Table 2. Incidence of HCMV infection in... | American Society of Hematology

Table 2.

Incidence of HCMV infection in the 80 HSCT recipients of the 2 randomization arms according to assay and type of allograft donor

	No. of patients (%) in the randomization arm
Parameter	IEmRNA	Antigenemia	P*	Total no. (%)
Positivity for HCMV
IEmRNAemia	33† (80.5)	29 (74.4)	NS	62 (77.5)
Antigenemia	26 (63.4)	20† (51.3)	NS	46 (57.5)
DNAemia	24 (58.5)	24 (61.5)	NS	48 (60.0)
Type of donor
UD	15 of 18 (83.3)	6 of 17 (35.3)	.006‡	21 of 35 (60.0)
Sibling	18 of 23 (78.3)	14 of 22 (63.7)	NS	32 of 45 (71.1)

	No. of patients (%) in the randomization arm
Parameter	IEmRNA	Antigenemia	P*	Total no. (%)
Positivity for HCMV
IEmRNAemia	33† (80.5)	29 (74.4)	NS	62 (77.5)
Antigenemia	26 (63.4)	20† (51.3)	NS	46 (57.5)
DNAemia	24 (58.5)	24 (61.5)	NS	48 (60.0)
Type of donor
UD	15 of 18 (83.3)	6 of 17 (35.3)	.006‡	21 of 35 (60.0)
Sibling	18 of 23 (78.3)	14 of 22 (63.7)	NS	32 of 45 (71.1)

NS indicates not significant.

Chi-square test.

The guiding assay of the relevant arm. Statistical comparison of the 2 guiding assays showed significant difference (P = .006).

Fisher exact test.